Medical device and technology company Lazurite™ will unveil its transformative ArthroFree™ wireless arthroscopic camera system at the combined annual meeting of the American Orthopedic Society for Sport Medicine (AOSSM) and the Arthroscopy Association of North America (AANA) at Music City Center in Nashville, Tenn., July 7-11, 2021.
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED™ 62 Reperfusion Catheter, the latest addition to the company’s comprehensive Penumbra System®.
The Tru-D® UVC disinfection device has been shown to be effective against Candida auris and Candida albicans in both direct and indirect line of sight, according to a new study, "Inactivation of Candida auris and Candida albicans by ultraviolet-C," in Infection Control and Hospital Epidemiology (ICHE).
Aspen Surgical Products, Inc. (“Aspen”), a leader in surgical disposable products, announced the acquisition of Stork® (“Stork”), a division of Briggs Healthcare.
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) announced today that its second-generation iQ+ has been approved for a Class III Medical Device License in Canada.
Shimadzu Medical Systems USA announces the North American sales release of our newest GLIDE Technology™ family member, the RADspeed Pro style edition with POWER GLIDE for general radiography.
XCO Tech Inc. and Atlazo, Inc. have announced the formation of Recon Health Inc., a joint venture to commercialize a portfolio of next generation virtual healthcare products based on embedded artificial intelligence (AI) edge computing and medical based analytics.
Essence Group, a leading provider of IoT solutions for the global security and care markets, today announced the launch of WeR@Home+, a next generation security and home management platform.
Harmonic Bionics, Inc., the robotics company for augmenting human movement, announced today the close of a $7 million Series A financing round led by KNet Investment Partners and Big Basin Capital.
Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, today announced it has secured $82 million in a Series B round, bringing total funding to date to $100 million.